The lab is the first to establish a normal reference interval of circulating miR‐122 concentrations in healthy dogs across several dog breeds. The result is miR-122 is now a commercially available diagnostic assay for canine liver disease at the miRVET Laboratory. Research is underway to offer a miR-122 assay service for other veterinary species and also for other microRNAs.